IFNA1 and COVID-19: Based on the findings that pDCs are the main cell type producing IFNα in response to SARS-CoV-2-infected cells, we sought to explore how this singular activation mechanism for IFN-I/λ response is modulated in the course of the infection in patients and how it could relate to COVID-19 severity.